View Past PerformanceMirion Technologies バランスシートの健全性財務の健全性 基準チェック /26Mirion Technologiesの総株主資本は$1.9B 、総負債は$1.2Bで、負債比率は63.6%となります。総資産と総負債はそれぞれ$3.5Bと$1.6Bです。 Mirion Technologiesの EBIT は$61.8Mで、利息カバレッジ比率2.5です。現金および短期投資は$397.9Mです。主要情報63.58%負債資本比率US$1.20b負債インタレスト・カバレッジ・レシオ2.5x現金US$397.90mエクイティUS$1.89b負債合計US$1.65b総資産US$3.54b財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesMirion Technologies, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending December 31, 2026Apr 29Mirion Technologies, Inc. to Report Q1, 2026 Results on Apr 28, 2026Apr 16Mirion Technologies, Inc., Annual General Meeting, May 13, 2026Apr 02Mirion Technologies, Inc. Announces Management AppointmentsFeb 11+ 1 more updateMirion Technologies, Inc. to Report Q4, 2025 Results on Feb 10, 2026Jan 22Mirion Technologies, Inc. (NYSE:MIR) completed the acquisition of Paragon Energy Solutions, LLC from Windjammer Capital Investors LLC.Dec 02Mirion Technologies, Inc. Reaffirms Earnings Guidance for the Full Year Ending December 31, 2025Oct 29Mirion Technologies, Inc. to Report Q3, 2025 Results on Oct 28, 2025Oct 16Mirion Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $369.565212 million.Sep 26Mirion Technologies, Inc. has filed a Follow-on Equity Offering in the amount of $349.999993 million.Sep 25Mirion Technologies, Inc. (NYSE:MIR) entered into a definitive agreement to acquire Paragon Energy Solutions, LLC from Windjammer Capital Investors LLC for approximately $590 million.Sep 24Mirion Technologies, Inc. Updates Earnings Guidance for the Fiscal Year Ending December 31, 2025Aug 01+ 1 more updateMirion Technologies Unveils the Vital Platform, a Digital Ecosystem Powering Integrated Operations for Nuclear Energy and BeyondJul 22Mirion Technologies, Inc. to Report Q2, 2025 Results on Jul 31, 2025Jul 17Mirion Technologies, Inc.(NYSE:MIR) dropped from Russell 3000E Value IndexJun 30+ 4 more updatesMirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio At Snmmi Annual MeetingJun 20Mirion Technologies, Inc. Revises Earnings Guidance for the Full Year 2025Apr 30Mirion Technologies, Inc. to Report Q1, 2025 Results on Apr 29, 2025Apr 21Mirion Technologies, Inc., Annual General Meeting, May 15, 2025Apr 03Mirion Technologies, Inc. to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard SoftwareApr 02Mirion Technologies Site in Munich Achieves ISO 19443 CertificationMar 01Mirion Technologies, Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2025Feb 13Mirion Technologies, Inc. to Report Q4, 2024 Results on Feb 11, 2025Jan 17Mirion Technologies, Inc. Provides Earnings Guidance for the Year 2025Dec 04Mirion Technologies, Inc. (NYSE:MIR) announces an Equity Buyback for $100 million worth of its shares.Dec 03Third quarter 2024 earnings released: US$0.066 loss per share (vs US$0.061 loss in 3Q 2023) Oct 30Mirion Technologies, Inc. Revises Financial Guidance for the Fiscal Year Ending December 31, 2024Oct 30New minor risk - Shareholder dilution Oct 21Mirion Technologies, Inc. to Report Q3, 2024 Results on Oct 29, 2024Oct 17New minor risk - Insider selling Aug 09Mirion Technologies, Inc. Reiterates Revenue Guidance for the Full Year Period Ending December 31, 2024Aug 03Second quarter 2024 earnings released: US$0.058 loss per share (vs US$0.14 loss in 2Q 2023) Aug 02New minor risk - Share price stability Aug 02Mirion Technologies, Inc. to Report Q2, 2024 Results on Aug 01, 2024Jul 20New minor risk - Shareholder dilution Jul 20New minor risk - Shareholder dilution Jun 11New minor risk - Shareholder dilution May 25No longer forecast to breakeven May 02First quarter 2024 earnings released: US$0.13 loss per share (vs US$0.22 loss in 1Q 2023) May 01Mirion Technologies, Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024May 01High number of new directors Apr 25Mirion Technologies, Inc., Annual General Meeting, Jun 04, 2024Apr 24New minor risk - Shareholder dilution Apr 24Mirion Technologies, Inc. to Report Q1, 2024 Results on Apr 30, 2024Apr 19Full year 2023 earnings released: US$0.49 loss per share (vs US$1.53 loss in FY 2022) Mar 04No longer forecast to breakeven Feb 15Full year 2023 earnings released: US$0.49 loss per share (vs US$1.53 loss in FY 2022) Feb 14Mirion Technologies, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2024Feb 14Mirion Technologies, Inc. to Report Q4, 2023 Results on Feb 13, 2024Feb 01Mirion Technologies, Inc. (NYSE:MIR) acquired Nuclear Medicine Information Systems, LLC for $33 million.Nov 03Third quarter 2023 earnings released: US$0.061 loss per share (vs US$0.26 loss in 3Q 2022) Nov 02Mirion Technologies, Inc. Reiterates Revenue Guidance for the Twelve Month Period Ending December 31, 2023Nov 02Mirion Announces Resignation of Michael Rossi as Medical Group President, Effective November 1, 2023Oct 19Mirion Technologies, Inc. to Report Q3, 2023 Results on Nov 01, 2023Oct 18New minor risk - Profitability Aug 04No longer forecast to breakeven Aug 03Mirion Technologies, Inc. Updates Its Revenue Guidance for the Fiscal Year Ending December 31, 2023Aug 03New minor risk - Shareholder dilution Jul 31Mirion Technologies, Inc. to Report Q2, 2023 Results on Aug 02, 2023Jul 23Mirion Technologies Introduces Genie™? 4.0 Spectroscopy Software, Now with Flexible Licensing OptionsJun 28Mirion Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $53.55 million.May 13Mirion Technologies, Inc. Reaffirms Revenue Guidance for the Fiscal Year Ending December 31, 2023May 06First quarter 2023 earnings released: US$0.22 loss per share (vs US$0.098 loss in 1Q 2022) May 03Mirion Technologies, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 2023Feb 15Full year 2022 earnings released Feb 15Mirion Technologies, Inc. to Report Q4, 2022 Results on Feb 14, 2023Feb 01No longer forecast to breakeven Nov 18Third quarter 2022 earnings released: US$0.26 loss per share (vs US$7.01 loss in 3Q 2021) Nov 03Mirion Technologies, Inc. Reaffirms Revenue Guidance for the Year 2022Nov 03Insufficient new directors Oct 31Mirion Technologies, Inc. to Report Q3, 2022 Results on Nov 01, 2022Oct 25Mirion Technologies Appoints Michael Rossi as President of Mirion MedicalOct 04Now 20% undervalued Oct 01Mirion Technologies, Inc. Announces Board ChangesSep 20Now 23% undervalued after recent price drop Sep 03Forecast breakeven date pushed back to 2023 Sep 01Mirion Technologies, Inc. (NYSE:MIR) acquired ARINC Incorporated from Collins Aerospace.Aug 10Second quarter 2022 earnings released: US$0.32 loss per share (vs US$8.14 loss in 2Q 2021) Jul 30Mirion Technologies, Inc. to Report Q2, 2022 Results on Jul 29, 2022Jul 16Mirion Technologies, Inc. Appoints Christopher Moore as Principal Accounting OfficerMay 21First quarter 2022 earnings released: US$0.098 loss per share (vs US$6.18 loss in 1Q 2021) May 08Insufficient new directors Apr 27Mirion Technologies, Inc., Annual General Meeting, Jun 15, 2022Apr 21+ 1 more updateMirion Technologies, Inc. Introduces New SaaS Option for its SunCHECK™ Quality Management PlatformApr 12Mirion Technologies, Inc. (NYSE:MIR) acquired Safeline Monitors Systems LLC for $1.5 million.Mar 10Full year 2021 earnings: Revenues in line with analyst expectations Mar 06Mirion Technologies, Inc. Announces Executive ChangesMar 06Mirion Technologies, Inc. Announces Executive ChangesFeb 24Mirion Technologies, Inc. to Report Q4, 2021 Results on Feb 23, 2022Feb 10Mirion Technologies, Inc. Launches the Hyperion™ Compact Digital Radiation Tolerant CameraDec 16First quarter 2022 earnings released: US$7.01 loss per share (vs US$3.58 loss in 1Q 2021) Nov 14財務状況分析短期負債: 55I0の 短期資産 ( $890.9M ) が 短期負債 ( $279.2M ) を超えています。長期負債: 55I0の短期資産 ( $890.9M ) は 長期負債 ( $1.4B ) をカバーしていません。デット・ツー・エクイティの歴史と分析負債レベル: 55I0の 純負債対資本比率 ( 42.5% ) は 高い と見なされます。負債の削減: 55I0は 5 年前には株主資本がマイナスでしたが、現在はプラスになっており、改善されています。債務返済能力: 55I0の負債は 営業キャッシュフロー によって 十分にカバーされていません ( 10.5% )。インタレストカバレッジ: 55I0の負債に対する 利息支払い は EBIT ( 2.5 x coverage) によって 十分にカバーされていません。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YTech 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/03 02:20終値2026/04/30 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Mirion Technologies, Inc. 8 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。12 アナリスト機関Quinn FredricksonBairdRobert MasonBairdYuan ZhiB. Riley Securities, Inc.9 その他のアナリストを表示
Mirion Technologies, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending December 31, 2026Apr 29
Mirion Technologies, Inc. (NYSE:MIR) completed the acquisition of Paragon Energy Solutions, LLC from Windjammer Capital Investors LLC.Dec 02
Mirion Technologies, Inc. Reaffirms Earnings Guidance for the Full Year Ending December 31, 2025Oct 29
Mirion Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $369.565212 million.Sep 26
Mirion Technologies, Inc. has filed a Follow-on Equity Offering in the amount of $349.999993 million.Sep 25
Mirion Technologies, Inc. (NYSE:MIR) entered into a definitive agreement to acquire Paragon Energy Solutions, LLC from Windjammer Capital Investors LLC for approximately $590 million.Sep 24
Mirion Technologies, Inc. Updates Earnings Guidance for the Fiscal Year Ending December 31, 2025Aug 01+ 1 more update
Mirion Technologies Unveils the Vital Platform, a Digital Ecosystem Powering Integrated Operations for Nuclear Energy and BeyondJul 22
Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio At Snmmi Annual MeetingJun 20
Mirion Technologies, Inc. to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard SoftwareApr 02
Mirion Technologies, Inc. (NYSE:MIR) announces an Equity Buyback for $100 million worth of its shares.Dec 03
Mirion Technologies, Inc. Revises Financial Guidance for the Fiscal Year Ending December 31, 2024Oct 30
Mirion Technologies, Inc. Reiterates Revenue Guidance for the Full Year Period Ending December 31, 2024Aug 03
Mirion Technologies, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2024Feb 14
Mirion Technologies, Inc. (NYSE:MIR) acquired Nuclear Medicine Information Systems, LLC for $33 million.Nov 03
Mirion Technologies, Inc. Reiterates Revenue Guidance for the Twelve Month Period Ending December 31, 2023Nov 02
Mirion Announces Resignation of Michael Rossi as Medical Group President, Effective November 1, 2023Oct 19
Mirion Technologies, Inc. Updates Its Revenue Guidance for the Fiscal Year Ending December 31, 2023Aug 03
Mirion Technologies Introduces Genie™? 4.0 Spectroscopy Software, Now with Flexible Licensing OptionsJun 28
Mirion Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $53.55 million.May 13
Mirion Technologies, Inc. Reaffirms Revenue Guidance for the Fiscal Year Ending December 31, 2023May 06
Mirion Technologies, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 2023Feb 15
Mirion Technologies, Inc. Introduces New SaaS Option for its SunCHECK™ Quality Management PlatformApr 12